CUSTOM CANCER VACCINES Trademark

Trademark Overview


On Wednesday, June 26, 2019, a trademark application was filed for CUSTOM CANCER VACCINES with the United States Patent and Trademark Office. The USPTO has given the CUSTOM CANCER VACCINES trademark a serial number of 88490613. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, June 30, 2020. This trademark is owned by Custom Cancer Vaccines, LLC. The CUSTOM CANCER VACCINES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for use in immunotherapies; anti-cancer preparations; pharmaceutical products for the detection, prevention, and treatment of cancer; biological preparations for the treatment of cancer and immunological diseases; pharmaceutical products for the prevention and treatment of cancer and immunological diseases; synthetic peptides for the treatment of cancer and immunological diseases; and vaccine preparations

Pharmaceutical research and development; research and development of pharmaceuticals for the treatment of cancer and immunological diseases; research and development of vaccines and medicines for the treatment of cancer and immunological diseases
custom cancer vaccines

General Information


Serial Number88490613
Word MarkCUSTOM CANCER VACCINES
Filing DateWednesday, June 26, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, June 30, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Disclaimer with Predetermined Text"CANCER VACCINES"
Goods and ServicesPharmaceutical preparations for use in immunotherapies; anti-cancer preparations; pharmaceutical products for the detection, prevention, and treatment of cancer; biological preparations for the treatment of cancer and immunological diseases; pharmaceutical products for the prevention and treatment of cancer and immunological diseases; synthetic peptides for the treatment of cancer and immunological diseases; and vaccine preparations
Goods and ServicesPharmaceutical research and development; research and development of pharmaceuticals for the treatment of cancer and immunological diseases; research and development of vaccines and medicines for the treatment of cancer and immunological diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 8, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 8, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCustom Cancer Vaccines, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92116

Trademark Events


Event DateEvent Description
Tuesday, June 30, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, June 30, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, December 18, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, December 18, 2019FINAL REFUSAL E-MAILED
Wednesday, December 18, 2019FINAL REFUSAL WRITTEN
Monday, December 16, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, December 15, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, December 15, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 16, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 16, 2019NON-FINAL ACTION E-MAILED
Monday, September 16, 2019NON-FINAL ACTION WRITTEN
Monday, September 16, 2019ASSIGNED TO EXAMINER
Monday, July 8, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 29, 2019NEW APPLICATION ENTERED IN TRAM